~~<i id='C6DDA98445'><strike id='C6DDA98445'><tt id='C6DDA98445'><pre id='C6DDA98445'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

knowledge

author：comprehensive 2025-09-30 00:03:11 - browse：6166

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： FDA approval of Sarepta Duchenne genetic therapy gives me hope

focus

entertainment

knowledge

leisure time

hotspot

knowledge

EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

WSS

Medical leaders decry Supreme Court decision on affirmative action

23andMe had bad news about my health. I wish a person had delivered it

How one medical school became remarkably diverse

Novo Nordisk testing Wegovy against alcohol

STAT reporters are Pulitzer Prize finalists for investigative reporting

FDA approval of Sarepta Duchenne genetic therapy gives me hope

hotspot

knowledge

focus

The cancer drug shortage isn’t new — and neither are the solutions

Dobbs anniversary: the lost opportunity of abortion as health care

After affirmative action ruling, medical educators look to 'holistic review'

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Drug repurposing or repositioning? The language matters

Supreme Court strikes down use of affirmative action

After affirmative action ruling, medical educators look to 'holistic review'

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

Medical leaders decry Supreme Court decision on affirmative action

ALS treatment from Biogen, Ionis fails in study

entertainment

Abbott's new stent may help patients with peripheral artery disease

United colonoscopy coverage change 'may cost lives,' doctors say

As H5N1 spreads in cows, experts warn against drinking raw milk

CVS is willing to dump 10% of its Medicare Advantage members

At least 13 dead in Texas as scorching temps continue

Affirmative action in medical school literally saved lives

knowledge

leisure time

hotspot

knowledge